evaluating the associations of variants in the UGT1A1 gene with the safety and efficacy of irinotecan monotherapy for pancreatic cancer in a Japanese cohort showed higher rates of neutropenia and anorexia in patients with UGT1A1 *6 and/or *28. The gene discussed is UGT1A1; the disease is neutropenia.